DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China · Delayed Price · Currency is CNY 18.50
-0.35 (-1.86%)
Aug 3, 2026, 3:00 PM CST
SHA:603233 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 6,897 | 6,509 | 6,217 | 4,416 | 4,493 | 2,792 |
Short-Term Investments | - | - | 6 | - | - | - |
Trading Asset Securities | 213.71 | 438.96 | 15.51 | 41.99 | 91.99 | 109.37 |
Cash & Short-Term Investments | 7,111 | 6,948 | 6,238 | 4,458 | 4,585 | 2,902 |
Cash Growth | 5.54% | 11.38% | 39.92% | -2.76% | 58.01% | -34.65% |
Accounts Receivable | 1,274 | 1,281 | 1,303 | 1,234 | 1,022 | 743.82 |
Other Receivables | 429.43 | 406.51 | 400.08 | 436.53 | 368.24 | 308.18 |
Receivables | 1,704 | 1,688 | 1,703 | 1,671 | 1,390 | 1,052 |
Inventory | 4,343 | 4,141 | 4,128 | 4,181 | 3,872 | 3,630 |
Prepaid Expenses | - | 3.86 | 3.35 | 11.97 | 39.03 | 43.79 |
Other Current Assets | 720.26 | 599.45 | 513.27 | 476.21 | 783.06 | 240.19 |
Total Current Assets | 13,878 | 13,381 | 12,586 | 10,798 | 10,670 | 7,868 |
Property, Plant & Equipment | 6,642 | 6,760 | 7,305 | 7,301 | 6,095 | 5,654 |
Long-Term Investments | - | 158.26 | 155.59 | 155.59 | 132.16 | 150.17 |
Goodwill | 3,468 | 3,468 | 3,522 | 3,024 | 2,364 | 2,060 |
Other Intangible Assets | 1,955 | 1,966 | 1,969 | 1,859 | 637.19 | 618.8 |
Long-Term Deferred Tax Assets | 219.55 | 217.8 | 231.61 | 214.48 | 186.31 | 157.57 |
Long-Term Deferred Charges | 486.31 | 515 | 648.03 | 670.03 | 663.03 | 669.76 |
Other Long-Term Assets | 180.8 | 21.79 | 22.22 | 101.12 | 94.19 | 157.99 |
Total Assets | 26,830 | 26,487 | 26,440 | 24,123 | 20,841 | 17,336 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 10,167 | 9,937 | 8,433 | 6,871 | 6,127 | 4,738 |
Accrued Expenses | 310.9 | 690.83 | 685.93 | 757.54 | 809.87 | 488.83 |
Short-Term Debt | 10.54 | 543.43 | 1,982 | 744.89 | 697.31 | 165.44 |
Current Portion of Long-Term Debt | 2,545 | 1,435 | 42.28 | 14.84 | 7.64 | - |
Current Portion of Leases | - | 1,107 | 1,177 | 1,041 | 974.67 | 905.59 |
Current Income Taxes Payable | 405.47 | 199.22 | 137.64 | 176.21 | 138.41 | 98.67 |
Current Unearned Revenue | 467.31 | 477.63 | 408.81 | 362.4 | 435.73 | 164.11 |
Other Current Liabilities | 1,062 | 677.48 | 839.68 | 1,486 | 516.59 | 615.14 |
Total Current Liabilities | 14,968 | 15,067 | 13,707 | 11,454 | 9,708 | 7,176 |
Long-Term Debt | 500.88 | 463.03 | 1,846 | 1,638 | 1,461 | 1,252 |
Long-Term Leases | 2,110 | 2,227 | 2,697 | 3,070 | 2,790 | 2,952 |
Long-Term Unearned Revenue | 14.68 | 14.98 | 17.42 | 19.3 | 17.64 | 20.12 |
Other Long-Term Liabilities | 53.73 | 53.42 | 34.84 | 9.67 | 0.33 | - |
Total Liabilities | 17,647 | 17,826 | 18,302 | 16,190 | 13,977 | 11,400 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,139 | 1,139 | 1,139 | 1,139 | 949.12 | 790.93 |
Additional Paid-In Capital | 1,252 | 1,259 | 1,288 | 1,355 | 1,537 | 1,643 |
Retained Earnings | 5,391 | 4,880 | 4,381 | 4,170 | 3,573 | 2,933 |
Treasury Stock | -100.74 | -100.74 | -100.74 | -29.72 | -36.68 | -77.59 |
Comprehensive Income & Other | 189.92 | 189.92 | 189.92 | 189.94 | 189.94 | 189.96 |
Total Common Equity | 7,871 | 7,368 | 6,897 | 6,824 | 6,212 | 5,479 |
Minority Interest | 1,311 | 1,294 | 1,241 | 1,109 | 652.27 | 457.3 |
Shareholders' Equity | 9,183 | 8,661 | 8,138 | 7,933 | 6,864 | 5,936 |
Total Liabilities & Equity | 26,830 | 26,487 | 26,440 | 24,123 | 20,841 | 17,336 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 5,167 | 5,775 | 7,744 | 6,508 | 5,931 | 5,275 |
Net Cash (Debt) | 1,944 | 1,173 | -1,506 | -2,050 | -1,346 | -2,373 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 1.70 | 1.03 | -1.33 | -1.81 | -1.18 | -2.10 |
Filing Date Shares Outstanding | 1,139 | 1,139 | 1,139 | 1,139 | 1,139 | 1,139 |
Total Common Shares Outstanding | 1,139 | 1,139 | 1,139 | 1,139 | 1,139 | 1,139 |
Working Capital | -1,090 | -1,687 | -1,121 | -655.27 | 962.03 | 692.26 |
Book Value Per Share | 6.91 | 6.47 | 6.06 | 5.99 | 5.45 | 4.81 |
Tangible Book Value | 2,448 | 1,934 | 1,406 | 1,941 | 3,211 | 2,800 |
Tangible Book Value Per Share | 2.15 | 1.70 | 1.23 | 1.70 | 2.82 | 2.46 |
Buildings | - | - | - | 2,016 | 1,076 | 800.43 |
Machinery | - | 1,761 | 1,598 | 1,460 | 1,257 | 1,119 |
Construction In Progress | - | 358.57 | 487.75 | 874.53 | 1,049 | 765.67 |